Comparative protective evaluation of curcumin and nano curcumin on the oxidative stress and other indices in the blood of experimental status epilepticus animal model

Main Article Content

Mohammad Ahmad Homood Alharbi Ahmad Alsadoun Abdualrahman Alshehry

Abstract

Background: Curcumin possesses antioxidant properties against oxidative damage, exerting powerful oxygen-free radical scavenging effects. The present study compares the protective effects of pre-treatment with curcumin and nanoparticles of curcumin on lithium pilocarpine-induced status epilepticus (SE) for oxidative damages and other blood indices in adult male rats.


Methods: The pretreated rats with curcumin and nano curcumin were induced with lithium pilocarpine-induced SE, and the non-enzymatic oxidative stress indices like lipid peroxides (TBARS), reduced total glutathione (GSH), as well as the enzymatic oxidative stress indices like catalase (CAT), glutathione S-transferase (GST), and superoxide dismutase (SOD), were estimated together in the blood cells with some blood indices in the serum.


Results: SE was able to induce a significant increase in TBARS and CAT and a substantial decrease in GSH, GST, and SOD levels in the blood cell tissues. The curcumin and nano curcumin pretreated groups significantly attenuated these oxidative stress indices. Furthermore, the blood indices like counts of red and white blood cells, platelets, hemoglobin, and packed cell volume were also depleted due to SE. Still, they were unaffected in the curcumin and nano curcumin pretreated groups. The serum enzyme levels of alkaline phosphatase, creatinine kinase, and other serum indices like high-density lipoprotein, urea, and glucose were decreased in the SE group. However, pretreatment with curcumin and nano curcumin ameliorated these serum indices.


Conclusion: The results indicate that oxidative stress indices in blood cells and other serum indices can be potential biomarkers for SE. Curcumin and nano curcumin may act as natural antioxidants for SE in the effective order of nano curcumin > curcumin. Further studies are required to ascertain the possibility of nano curcumin as an antiepileptic natural product.

Article Details

How to Cite
AHMAD, Mohammad et al. Comparative protective evaluation of curcumin and nano curcumin on the oxidative stress and other indices in the blood of experimental status epilepticus animal model. Medical Research Archives, [S.l.], v. 13, n. 1, jan. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6240>. Date accessed: 10 feb. 2025. doi: https://doi.org/10.18103/mra.v13i1.6240.
Section
Research Articles

References

1. Farombi EO, Ekor M. Curcumin attenuates gentamicin-induced renal oxidative damage in rats. Food Chem Toxicol. 2006; 44:1443-48.
2. El-Demerdash FM, Yousef MI, Radwan FM. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol. 2009; 47:249-54.
3. Du P, Tang HY, Li X, Lin HJ, Peng WF, Ma Y, Fan W, Wang X. Anticonvulsive and antioxidant effects of curcumin on pilocarpine-induced seizures in rats. Chin Med J. 2012;125:1975-9.
4. Chen S, Fujita S, Koshikawa N, Kobayashi M. Pilocarpine-induced status epilepticus causes acute interneuron loss and hyper-excitatory propagation in rat insular cortex. Neuroscience. 2010;166: 341-53.
5. Freitas RM. Investigation of oxidative stress involvement in hippocampus in epilepsy model induced by pilocarpine. Neurosci Lett. 2009; 462: 225-29.
6. Aboul Ezz HS, Khadrawy YA, Noor NA. The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem Res. 2011; 36: 2195-204.
7. Ahmad M. Protective effects of curcumin against lithium–pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats. Saudi J Biol Sc. 2013; 20:155-62.
8. Tariq M, Ahmad M, Moutaery KA, Deeb SA. Pentoxifylline ameliorates lithium–pilocarpine induced status epilepticus in young rats. Epilepsy Behav. 2008; 12: 354-65.
9. Gorter JA, van Vliet EA, Aronica E. Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis. Epilepsy Behav. 2015; 49: 13-16,
10. Pont F, Collet A, Lallement G. Early and transient increase of rat hippocampal blood-brain barrier permeability to amino acids during kainic acid-induced seizures. Neurosci Lett. 1995; 184:52-54
11. Roch C, Leroy C, Nehlig A. Magnetic resonance imaging in the study of the lithium–pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia. 2002; 43:325-35
12. Freitas RL, Santos IM, De Souza GF, Tome Ada R, Saldanha GB, Freitas RM. Oxidative stress in rat hippocampus caused by pilocarpine-induced seizures is reversed by buspirone. Brain Res Bull. 2010; 81:505-09.
13. Choudhary KM, Mishra A, Poroikov VV, Goel RK. Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol. 2013; 15: 33-40.
14. Adami R, Bottai D. Curcumin and neurological diseases. Nutr Neurosci. 2020; 22: 1-21.
15. Persinger MA, Bureau YRJ, Kostakos M, Peredery O, Falter H. Behaviors of rats with insidious multifocal brain damage induced by seizures following single peripheral injections of lithium and pilocarpine. Physiol Behav. 1993; 53: 849-56.
16. Ahmad M, Abu-Taweel GM, Hidayathulla S. Nano-composites chitosan-curcumin synergistically inhibits the oxidative stress induced by toxic metal cadmium. Int J Biol Macro. 2017; 108: 1-28.
17. Sorg DA, Buckner B. A simple method of obtaining venous blood from small laboratory animals. Proc Sec Exp Med. 1964;115: 1131-32.
18. Ceballos-Picot I, Triever JV, Nicole A, Silnet PM, Thevenin M. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem. 1992; 38: 66-70.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-58.
20. Mangino MJ, Murphy MK, Glabar GG. Protective effects of glycine during hypothermic renal ischemic reperfusion injury. Am J Physiol. 1991; 261: F841-48.
21. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem.1974; 249: 7130-39.
22. Aebi H. Catalase, in Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., 1972; vol. 2, Academic Press, New York, NY, USA.
23. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, J Biol Chem. 1972; 247: 3170-5.
24. Schumann G, Dominick HC, Hellmann D, Klauke R, MöckeschM, Stekel H, von Schenck H, Kraft M, Nagel R, Hänseler E. Alkaline phosphatase activity: new assay for the Reflotron system. Results of the evaluation in eight clinical laboratories. Clin Chem Lab Med. 2001; 39: 71-8.
25. Deneke U, Rittersdorf W. Evaluation of the refloquant GPT (ALT) reagent carriers with reflotron. Clin Chem. 1984; 30: 1009.
26. Deneke U, Rittersdorf W, Werner W. Performance data of Reflotron-GOT (AST) dry chemistry test for Reflotron. Clin Chem. 1985; 31: 921.
27. Horder M, Jorgensen PJ, Hafkenscheid JC, Carstensen CA, Bachmann C, Bauer K, Neuwald C, Rosalki SB, Foo AY, Vogt W. Creatine kinase determination: a European evaluation of the creatine kinase determination in serum, plasma and whole blood with the Reflotron system. Eur J Clin Chem Clin Biochem. 1991; 29: 691-6.
28. Kinlay S. Comparison of Reflotron and laboratory cholesterol measurements. Med J Aust. 1988; 149: 126-9.
29. Price CP, Koller PU. A multicentre study of the new Reflotron system for the measurement of urea, glucose, triacylglycerols, cholesterol, gamma-glutamyltransferase and haemoglobin. J Clin Chem Clin Biochem. 1988; 26: 233-50.
30. Paschen K, Hagemann P, Lang HR, Cortes M, Weidemann G, Tof-faletti J, Burritt M, Leinberger R, Tritschler W, Ramstetter E. Determination of potassium by dry reagent carrier technology: a multicentre evaluation. Eur J Clin Chem Clin Biochem. 1993; 31: 545-52.
31. Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, Kowall NW, Rosen BR, Beal MF. Involvement of free radicals in excitotoxicity in vivo. J Neurochem. 1995; 64: 2239-47.
32. Reeta KH, Mehla J, Pahuja M, Gupta YK. Pharmacokinetic and pharmacodynamic interaction of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol Biochem Behav. 2011; 99: 399-407.
33. Ataie A, Sabetkasaei M, Haghparast A, Moghaddam AH, Kazeminejad B. Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rats. Pharmacol Biochem Behav. 2010; 96: 378-85.
34. Noor NA, Aboul Ezz HS, Faraag AR, Khadrawy YA. Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav. 2012; 24: 199-206.
35. Hayes JD, Flangan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxi-col. 2005; 45: 51-88.
36. Cathcart RF. Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger. Med Hypotheses. 1985; 18: 61-77.
37. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev. 1994; 74: 139-65.
38. Kielczykowska M, Pasternak K, Musik I, Wroniska J. The effect of lithium administration in a diet on the chosen parameters of the antioxidant barrier in rats. Ann Univ Mariae Curie Sklodowska Med. 2004; 59: 140-5.
39. Rahman MF, Siddiqui MK, Jamil K. Effects of Vepacide (Azadirachta indica) on aspartate and alanine aminotransferase profiles in a subchronic study with rats. Drug Chem Toxicol. 2000; 23: 497-509.